Veeva Corp (VEEV): Price-to-Revenue Coefficient

Brandmark of Veeva Systems (VEEV)

The industry-average P/S for Veeva Systems Inc. (VEEV) reflects market valuation dynamics, where the value 14.10 represents the current metric. Business growth relies on the automation of cloud services, which minimizes personnel costs. The company's monopolist status in the pharma sector is cemented by the deep integration of its software into regulatory processes. Veeva Systems Inc. (VEEV) is currently undergoing a risky architectural transformation, implementing artificial intelligence and its own CRM system.

VEEV Veeva Price-to-Revenue Ratio (07/04/2022 - 11/13/2026)

Analytical breakdowns for Veeva Systems Inc (VEEV)

- share price and consensus valuation forecast:
Fundamental company analysis:VEEV (veeva.com)
Brand item of Veeva

Veeva Systems Inc. (VEEV) maintains a monopoly status within the pharmaceutical software segment, where stringent FDA standards create high barriers to entry, justifying the business's premium valuation. By analyzing the company's current P/S ratio, an investor can weigh market capitalization against actual revenue, allowing them to filter out speculative noise from fundamental growth and avoid purchasing an overvalued asset during a market bubble phase.

Competitors of Veeva Systems Inc.

DOCS (doximity.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio HealthEquity HQY|Price-to-Revenue Coefficient Waystar Health (WAY)|CRVL: Market Cap to Revenue|Price to Sales Privia Medical Group|Huron Consulting Group (HURN) - Price-to-Revenue Ratio|CERT - Price-to-Revenue Coefficient|Market Cap to Revenue OMCL|GDRX (GoodRx Inc) - Market Cap to Sales Volume|P/S Multiple SDGR|PHR - Price to Sales|Price-to-Revenue Ratio Omada Health Inc OMDA|EVH - Market Cap to Revenue|HSTM - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Definitive Healthcare Corp DH|CCSI (Consensus) - Market Cap to Revenue|Agilon Health Corp - Market Capitalization-to-Revenue Ratio|ABSI (Absci) - P/S Multiple|soyoung.com (SY) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio nrchealth.com (NRC)|Spok Holdings Inc - Market Cap to Revenue Ratio|P/S Multiple OPRX (OptimizeRx Corp.)|TBRG - Market Cap to Revenue|SLP: Market Cap to Revenue|Price-to-Revenue Coefficient SOPHiA GENETICS SA SOPH|HCAT (Health Catalyst) - Market Cap to Revenue|CCLD (CareCloud) - Price-to-Revenue Ratio|RSSS (Research Solutions, Inc.) - P/S Multiple|Price to Sales DLH Holdings Corp DLHC|P/S Multiple ONMD|SCNX - Price to Sales|Healthcare Triangle, Inc. - Market Cap to Revenue|iSpecimen Inc - Price-to-Revenue Ratio|Bullfrog AI Holdings Inc - P/S Multiple|Price-to-Revenue Coefficient SCWorx Inc WORX|MSPR (MSP Recovery Inc) - Market Cap to Revenue|ICCT: Market Cap to Sales Volume|Market Cap to Revenue MEDS|ORGS: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio R1 RCM Inc. (RCM)|Market Cap to Revenue Sharecare Inc SHCR|P/S Multiple STRM (Streamline Health Solutions)|syrahealth.com (SYRA) - Price to Sales|ApolloMed - P/S Multiple|MODN (Model N Inc) - Market Cap to Revenue Ratio|NXGN (NextGen) - Market Cap to Revenue